BROWN ADVISORY INC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.

Quarter-by-quarter ownership
BROWN ADVISORY INC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$113,687,000
+1.2%
752,048
-2.5%
0.22%
+4.7%
Q2 2022$112,368,000
+7.3%
771,172
-12.7%
0.21%
+35.3%
Q1 2022$104,765,000
-10.4%
883,570
+4.1%
0.16%
+7.6%
Q4 2021$116,984,000
-18.5%
848,879
-17.8%
0.14%
-31.6%
Q3 2021$143,523,000
+42.0%
1,033,202
-0.8%
0.21%
+39.5%
Q2 2021$101,097,000
+49.5%
1,041,365
+5.2%
0.15%
+31.0%
Q1 2021$67,644,000
-11.2%
989,688
+11.4%
0.12%
-14.1%
Q4 2020$76,135,000
+36.3%
888,284
+3.4%
0.14%
+17.4%
Q3 2020$55,868,000
-9.9%
859,393
+1.3%
0.12%
-20.1%
Q2 2020$61,999,000
+133.4%
848,019
+8.7%
0.14%
+77.8%
Q1 2020$26,559,000
-31.1%
780,441
+10.3%
0.08%
-17.3%
Q4 2019$38,527,000
-15.3%
707,684
-35.1%
0.10%
-23.4%
Q3 2019$45,475,000
+3.0%
1,089,992
+8.1%
0.13%
+1.6%
Q2 2019$44,144,000
+36.7%
1,008,046
+60.7%
0.13%
+37.0%
Q1 2019$32,285,000
+92.6%
627,282
+38.3%
0.09%
+64.3%
Q4 2018$16,766,000453,4090.06%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders